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likely function in the pathway for 
“excitation-transcription coupling” 
in the heart. Inositol 1,4,5-trisphos-
phate receptors in the nuclear enve-
lope mediate spatially restricted cal-
cium release, which is instrumental 
to this process (Wu et al., 2006).
The present report in Cell poses 
as many exciting questions as it 
answers—a very fair and rewarding 
trade. How does CAMTA2 engage a 
growth program—is Nkx2-5 or some 
other DNA bound factor the critical 
intermediate for growth? Given the 
many growth factors that are induced 
or activated in hypertrophic cells, 
are the trophic effects of CAMTA 
exclusively cell autonomous? Does 
CAMTA2 participate in those aspects 
of hypertrophy that were not yet stud-
ied (the predisposition to cell death, 
the dysregulation of nuclear genes 
for mitochondrial proteins, the loss 
of αMHC and calcium-handling pro-
teins) or in those modes of hypertro-
phy referred to as more “physiologi-
cal” because they are triggered by 
exercise or the IGF-PI3K-Akt path-
way? Even if CAMTA2 and CAMTA1 
are functionally indistinguishable as 
ascertained in vitro, the differential 
expression of CAMTA1 (in the early 
stages of heart development) versus 
CAMTA2 (at later ages) prompts the 
speculation that CAMTA1 might have 
the more obvious place in both car-
diac development and in human con-
genital heart disease.
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One goal of biomedical research is to reliably construct surrogate tissues for replacement 
therapy and to promote tissue regeneration. In this issue of Cell, Chun et al. (2006) provide 
insight into the molecular basis of tissue-specific differentiation. The authors show that 
remodeling of the extracellular matrix by the matrix metalloproteinase MT1-MMP contrib-
utes to the three-dimensional development of white adipose tissue in mice.Tissue development proceeds 
within the context of an organized 
extracellular matrix (ECM) micro-
environment and is temporally con-
trolled by transcriptional programs 
initiated by soluble and insoluble 
cues. Tissues are three dimen-
sional (3D) and exert—and are sub-
ject to—forces that profoundly alter 
their behavior. Dynamic extrinsic 
and intrinsic forces modify cell fate 
by influencing membrane-receptor and ion-channel activity, by alter-
ing cytoskeletal organization and 
nuclear shape, and by modulat-
ing tissue organization and gene 
expression (for review, see Orr et 
al., 2006). As development pro-
ceeds, increasingly elaborate and 
specialized 3D tissue structures 
are assembled, with the cytoarchi-
tecture and tissue-specific forces 
in each organ reflecting the spe-
cialized function of the tissue (for Cell 12review, see Nelson et al., 2005). As 
each specialized tissue develops, 
it produces a unique biochemical 
and organizational ECM in which 
it becomes enmeshed. The ECM 
in turn influences the ability of 
the tissue to sense the magnitude 
and duration of extrinsic forces. 
This force then impacts signaling 
cascades that direct expression 
of genes important for differentia-
tion. Accordingly, the biochemical 5, May 5, 2006 ©2006 Elsevier Inc. 429
composition and organization of 
the ECM—and the molecules and 
mechanisms that regulate ECM 
synthesis, deposition, maturation, 
and remodeling—are critical force-
linked morphogenetic regulators of 
tissue differentiation.
Matrix metalloproteinases (MMPs) 
comprise a family of over 20 pro-
teolytic enzymes intimately 
involved in remodeling the 
ECM. Secreted or mem-
brane-associated MMPs have 
overlapping substrate speci-
ficities; however, in some 
specialized tissues, MMPs 
have a tissue-specific func-
tion (for review, see Sternlicht 
and Werb, 2001). For exam-
ple, MMP-3 plays a key role 
in remodeling the mammary 
gland by degrading the base-
ment membrane and thereby 
removing survival signals for 
nonfunctional epithelial cells. 
In other instances, MMPs act 
by liberating soluble factors 
entrapped in the adjacent 
matrix required for subse-
quent tissue remodeling. For 
example, MMP-9 is a critical 
mediator of blood-vessel for-
mation during bone repair and 
pancreatic tumor progression, 
where it releases VEGF that is 
bound in the adjacent stromal 
matrix (for review, see Mott 
and Werb, 2004).
A dramatic example of the 
profound effect of a failure to 
remodel ECM on tissue devel-
opment is provided by the 
phenotype of the MT1-MMP knock-
out mouse. In this model, loss of 
the MT1-MMP membrane-anchored 
protease results in dwarfism, osteo-
penia, arthritis, and fibrosis that cul-
minate in the premature death of the 
animal (Holmbeck et al., 1999). The 
mice also display general connec-
tive-tissue abnormalities, underscor-
ing the essential role of pericellular 
proteolysis in tissue differentiation 
and homeostasis. Despite these 
striking phenotypes, the precise 
molecular mechanisms that drive 
such a global, severe phenotype 
have yet to be clearly defined.
In this issue of Cell, Chun et 
al. (2006) shed new light on how 
remodeling of the ECM by the peri-
cellular collagenase MT1-MMP 
contributes to proper development 
of white adipose tissue in mice. 
The authors show that the compo-
sition and dimensions of the ECM 
are two critical yet interdependent 
determinants that regulate tissue-
specific differentiation. Mice lack-
ing MT1-MMP display profoundly 
compromised differentiation of 
cells into adipocytes (fat cells) in 
vivo. Cells from these mice show 
an altered transcriptional profile of 
genes important in adipocyte dif-
ferentiation, and there is increased 
deposition of collagen in the ECM 
of white adipose tissue. However, 
when preadipocytes isolated from 
MT1-MMP-deficient animals were 
grown on rigid two-dimensional 
(2D) collagen gels and induced to 
differentiate, they consistently dis-
played differentiation markers and 
an adipocyte-like morphology (Fig-
ure 1). Interestingly, if these same 
cells were transplanted into wild-
type mice expressing MT1-MMP, 
they failed to form normal adipose 
tissue and instead deteriorated into 
shriveled nondifferentiated entities. 
Because matrix stiffness is a key 
regulator of cell and tissue 
differentiation, the authors 
grew single cells lacking 
MT1-MMP on 2D collagen 
gels of varying matrix stiff-
ness and examined adipo-
cyte differentiation. Cells 
lacking MT1-MMP differ-
entiated efficiently into adi-
pocytes regardless of the 
stiffness of the 2D ECM. 
These results are not sur-
prising, as it is known that a 
cell will integrate the forces 
it encounters from all three 
dimensions—even when, 
as in this case, the third 
dimension is the culture 
medium—and alter its cyto-
architecture, shape, and 
contractility based upon the 
average stiffness of its com-
bined 3D matrices (Beningo 
et al., 2004).
Consistently, when the 
authors transferred MT1-
MMP-deficient cells into 3D 
collagen gels such that they 
were surrounded on all sides 
by a relatively uniform stiff 
collagen matrix, they failed 
to differentiate appropriately. 
However, MT1-MMP-deficient 
cells differentiated if the collagen 
concentration and matrix stiffness 
were reduced substantially or matrix 
compliance was increased through 
ectopic expression of MT1-MMP 
(Figure 1). Interestingly, the morphol-
ogy of the MT1-MMP-deficient adi-
pocytes in a rigid 3D microenviron-
ment was dramatically altered. This 
suggests that the force imposed by 
the stiffness of the matrix impaired 
the acquisition of a cellular archi-
tecture necessary to propagate and 
sustain the appropriate intracellular 
signals upon exposure to differentia-
tion stimuli.
figure 1. Adipocyte Differentiation in 3D
(Left) Adipocytes from wild-type mice differentiated in a 3D 
collagen I matrix.
(Right) MT1-MMP null adipocytes failed to differentiate in 
MT1-MMP null mice; however, they efficiently differentiated 
when grown as 2D monolayers on either compliant or rigid 
matrices. Yet when embedded within a dense 3D collagen I 
network, they did not differentiate unless either the density 
or concentration of the collagen I network was reduced or 
the cells could remodel the matrix by ectopically expressing 
MT1-MMP.  430 Cell 125, May 5, 2006 ©2006 Elsevier Inc.
These studies clearly emphasize 
the importance of force exerted by 
the matrix in tissue-specific differ-
entiation. Additionally, the Chun et 
al. (2006) study highlights the criti-
cal role of localized MMPs in per-
mitting the correct cell shape and 
cytoarchitecture required for tissue 
differentiation. Moreover, the work 
is reminiscent of historical stud-
ies illustrating how mammary and 
salivary gland differentiation pro-
ceeds most efficiently when the 
epithelial cells adopt the correct 
“rounded” cell shape. Thereafter, 
these rounded cells assemble into 
organized 3D-tissue-like structures 
once in contact with a compliant 3D 
ECM (for review, see Roskelley et al., 
1995). This study also concurs with 
recent work demonstrating that the 
stiffness of a 3D ECM can severely 
compromise mammary epithelial 
cell differentiation. It also supports 
the finding that stem cell differen-
tiation can be profoundly altered by 
cell shape, which is determined by 
force exerted by the matrix (Paszek 
et al., 2005; McBeath et al., 2004).
Although the molecular mecha-
nisms by which matrix deposition 
and orientation are controlled are 
still being defined, MMPs clearly 
play a critical role. The Chun et 
al. (2006) study emphasizes the 
importance of matrix organization, 
orientation, and remodeling in tis-
sue-specific differentiation. Thus, 
the restricted differentiation of adi-
pocytes, severely reduced depos-
its of white adipose tissue, and 
reduced energy stores in the MT1-
MMP knockout mouse not only 
reflect altered cell shape and matrix 
stiffness linked to the absence of 
appropriate matrix remodeling but 
underscore the requirement for 
localized proteolysis of adjacent 
matrices. Moreover, previous stud-ies using osteogenic cells from 
MT1-MMP-deficient mice showed 
that differentiation of osteogenic 
cells could not be rescued even 
when the cells were transplanted 
into wild-type animals. This sug-
gests that lack of localized peri-
cellular proteolysis and sustained 
force exerted by the matrix inter-
feres with the differentiation pro-
gram in other tissues.
With respect to the molecular 
mechanism, collagen proteolysis 
can expose cryptic ligands that are 
then free to engage different integ-
rin receptors and initiate new sig-
nals in cells that can differentially 
impact cell behavior. In addition, 
proteolytic activity can generate 
fragments of biologically active 
molecules that may have activities 
distinct from those of their full-
length counterparts, profoundly 
altering cell and tissue behavior (for 
review, see Mott and Werb, 2004). 
However, preadipocytes from mice 
lacking MT1-MMP that were cul-
tured on collagen gels could dif-
ferentiate into mature adipocytes, 
suggesting that proteolysis of col-
lagen per se was not required to 
expose essential ligands or gener-
ate new fragments with new bio-
logical activities. Instead, reducing 
the tension of the collagen matrix 
appeared to be key for permitting 
adipocytes lacking MT1-MMP to 
regain their ability to secrete leptin 
and express other markers of adi-
pocyte differentiation. Although the 
precise mechanisms by which stiff 
3D matrices prevent differentiation 
were not fully defined, the work of 
Chun and colleagues (2006) raises 
the interesting possibility that an 
additional dynamic, spatially linked, 
and mechanically sensitive mecha-
nism is essential for normal tissue 
development and morphogenesis.Cell 12Historically, the ECM was largely 
viewed as simply providing structural 
integrity to tissues. More recently, 
with the discovery of integrin recep-
tors and their associated signaling 
pathways and a better understand-
ing of the dynamic instructive nature 
of the ECM, the physical role of the 
ECM has been largely forgotten. Now, 
an emerging body of work seems to 
intimately link both the physical and 
molecular signals elicited by interac-
tions between cells and the ECM, 
providing a more comprehensive 
and integrated understanding of 
the dynamic, reciprocal interactions 
required for tissue-specific gene 
expression and morphology.
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